DNAJC13 Gene PARK21 Parkinson NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Parkinson’s Disease
The DNAJC13 Gene PARK21 Parkinson NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with PARK21-linked Parkinson’s disease. This advanced genetic screening utilizes cutting-edge Next-Generation Sequencing (NGS) technology to analyze the DNAJC13 gene, providing crucial insights for individuals at risk of hereditary Parkinson’s disease.
What This Test Measures and Detects
This specialized genetic test specifically targets the DNAJC13 gene, which has been scientifically linked to PARK21, a familial form of Parkinson’s disease. The test identifies:
- Pathogenic variants in the DNAJC13 gene sequence
- Specific mutations associated with early-onset Parkinson’s disease
- Genetic markers indicating increased susceptibility to neurological degeneration
- Inheritance patterns that may affect family members
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Early-onset Parkinson’s symptoms before age 50
- Family history of Parkinson’s disease across multiple generations
- Tremors, rigidity, or bradykinesia with unclear etiology
- Progressive neurological symptoms with suspected genetic component
- Planning for family and wanting to understand hereditary risks
Key Benefits of DNAJC13 Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Early Risk Assessment: Identify genetic predisposition before symptom onset
- Personalized Treatment Planning: Enable targeted therapeutic approaches
- Family Planning Guidance: Make informed decisions about genetic inheritance
- Proactive Health Management: Implement preventive strategies based on genetic profile
- Clinical Trial Eligibility: Access to specialized Parkinson’s research studies
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and neurologists:
- Positive Result: Indicates presence of DNAJC13 mutation associated with PARK21 Parkinson’s disease risk
- Negative Result: No detected mutations in the DNAJC13 gene analyzed
- Variant of Uncertain Significance: Genetic changes with unclear clinical implications requiring further evaluation
All results include comprehensive genetic counseling to ensure proper understanding and next steps.
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | DNAJC13 Gene PARK21 Parkinson NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Pre-Test Requirements
Before scheduling your test, we recommend:
- Complete clinical history documentation
- Genetic counseling session to create family pedigree chart
- Discussion of testing implications with healthcare provider
- Understanding of potential psychological impact of results
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic testing centers ensures accessible, reliable service nationwide.
Take Control of Your Neurological Health Today
Don’t wait to gain crucial insights into your genetic predisposition for Parkinson’s disease. Our expert team of neurologists and genetic counselors are ready to guide you through the testing process and help you understand your results.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your DNAJC13 Gene PARK21 Parkinson NGS Genetic DNA Test and take the first step toward proactive neurological health management.
Early detection through advanced genetic testing can make a significant difference in managing Parkinson’s disease risk and planning for optimal neurological health outcomes.
